Atomic mapping of the sugar interactions in one-site and two-site mutants of cyanovirin-N by NMR spectroscopy

Biochemistry

Volumn 47, Issue 12, 2008, Pages 3625-3635

  Sandström, Corine ^a   Hakkarainen, Birgit ^a   Matei, Elena ^b   Glinchert, Anja ^c   Lahmann, Martina ^d   Oscarson, Stefan ^c   Kenne, Lennart ^a   Gronenborn, Angela M ^b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d BANGOR UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC MAPPING; PROTEIN BINDING SITE; TRIMANNOSIDES;

BINDING ENERGY; MUTAGENESIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SUGAR (SUCROSE); VIRUSES;

PROTEINS;

CYANOVIRIN N; DISACCHARIDE; MANNOSIDE; METHYL 2 DEOXY ALPHA DEXTRO ARABINO HEXOPYRANOSYL(1-2)ALPHA DEXTRO MANNOPYRANOSIDE; METHYL 3 DEOXY ALPHA DEXTRO ARABINO HEXOPYRANOSYL(1-2)ALPHA DEXTRO MANNOPYRANOSIDE; METHYL 4 DEOXY ALPHA DEXTRO LYXO HEXOPYRANOSYL(1-2)ALPHA DEXTRO MANNOPYRANOSIDE; METHYL 6 DEOXY ALPHA DEXTRO MANNOPYRANOSYL(1-2)ALPHA DEXTRO MANNOPYRANOSIDE; SUGAR; TRISACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BINDING SITES; CARRIER PROTEINS; EPITOPE MAPPING; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOSACCHARIDES;

EID: 41149114081     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi702200m     Document Type: Article

References (36)

1. Boyd, M. R., Gustafson, K. R., McMahon, J. B., Shoemaker, R. H., Okeefe, B. R., Mori, T., Gulakowski, R. J., Wu, L., Rivera, M. I., Laurencot, C. M., Currens, M. J., Cardellina, J. H., Buckheit, R. W., Nara, P. L., Pannell, L. K., Sowder, R. C., and Henderson, L. E. (1997) Discovery of Cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development. Antimicrob. Agents Chemother. 41, 1521-1530.
2. Esser, M. T., Mori, T., Mondor, I., Sattentau, Q. J., Dey, B., Berger, E. A., Boyd, M. R., and Lifson, J. D. (1999) Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J. Virol. 73, 4360-4371.
3. Dey, B., Lerner, D. L., Lusso, P., Boyd, M. R., Elder, J. H., and Berger, E. A. (2000) Multiple antiviral activities of Cyanovirin-N: Blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses. J. Virol. 74, 4562-4569.
4. 1,2 and inhibits infectivity of Ebola virus. Antiviral Res. 58, 47-56.
5. O'Keefe, B. R., Smee, D. F., Turpin, J. A., Saucedo, C. J., Gustafson, K. R., Mori, T., Blakeslee, D., Buckheit, R., and Boyd, M. R. (2003) Potent anti-influenza activity of Cyanovirin-N and interactions with viral hemagglutinin. Antimicrob. Agents Chemother. 47, 2518-2525.
6. Barrientos, L. G., and Gronenborn, A. M. (2005) The highly specific carbohydrate-binding protein Cyanovirin-N: Structure, anti-HIV/Ebola activity and possibilities for therapy. Rev. Med. Chem. 5, 21-31.
7. O'Keefe, B. R., Shenoy, S. R., Xie, D., Zhang, W. T., Muschik, J. M., Currens, M. J., Chaiken, I., and Boyd, M. R. (2000) Analysis of the interaction between the HIV-inactivating protein Cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41. Mol. Pharmacol. 58, 982-992.
8. Bolmstedt, A. J., O'Keefe, B. R., Shenoy, S. R., McMahon, J. B., and Boyd, M. R. (2001) Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol. Pharmacol. 59, 949-954.
9. Shenoy, S. R., O'Keefe, B. R., Bolmstedt, A. J., Cartner, L. K., and Boyd, M. R. (2001) Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins. J. Pharmacol. Exp. Ther. 297, 704-710.
10. Bewley, C. A., Gustafson, K. R., Boyd, M. R., Covell, D. G., Bax, A., Clore, G. M., and Gronenborn, A. M. (1998) Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat. Struct. Biol. 5, 571-578.
11. Yang, F., Bewley, C. A., Louis, J. M., Gustafson, K. R., Boyd, M. R., Gronenborn, A. M., Clore, G. M., and Wlodawer, A. (1999) Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J. Mol. Biol. 288, 403-412.
12. Bewley, C. A. (2001) Solution structure of a Cyanovirin-N:Manα1- 2Manα complex: Structural basis for high-affinity carbohydrate-mediated binding to gp120. Structure 9, 931-940.
13. Barrientos, L. G., Louis, J. M., Botos, I., Mori, T., Han, Z. Z., O'Keefe, B. R., Boyd, M. R., Wlodawer, A., and Gronenborn, A. M. (2002) The domain-swapped dimer of Cyanovirin-N is in a metastable folded state: Reconcilition of X-ray and NMR structures. Structure 10, 673-686.
14. Botos, I., O'Keefe, B. R., Shenoy, S. R., Cartner, L. K., Ratner, D. M., Seeberger, P. H., Boyd, M. R., and Wlodawer, A. (2002) Structures of the complexes of a potent anti-HIV protein Cyanovirin-N and high mannose oligosaccharides. J. Biol. Chem. 277, 34336-34342.
15. Barrientos, L. G., Louis, J. M., Ratner, D. M., Seeberger, P. H., and Gronenborn, A. M. (2003) Solution structure of a circular-permuted variant of the potent HIV-inactivating protein CyanovirinN: Structural basis for protein stability and oligosaccharide interaction. J. Mol. Biol. 325, 211-223.
16. 9 with nanomolar affinity: Implications for binding to the HIV envelope protein gp120. J. Am. Chem. Soc. 123, 3892-3902.
17. Shenoy, S. R., Barrientos, L. G., Ratner, D. M., O'Keefe, B. R., Seeberger, P. H., Gronenborn, A. M., and Boyd, M. R. (2002) Multisite and multivalent binding between Cyanovirin-N and branched oligomannosides: Calorimetric and NMR characterization. Chem. Biol. 9, 1109-1118.
18. 9. J. Mol. Biol. 322, 881-889.
19. Mayer, M., and Meyer, B. (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem., Int. Ed. 38, 1784-1788.
20. Klein, J., Meinecke, R., Mayer, M., and Meyer, B. (1999) Detecting binding affinity to immobilized receptor proteins in compound libraries by HR-MAS STD NMR. J. Am. Chem. Soc. 121, 5336-5337.
21. Vogtherr, M., and Peters, T. (2000) Application of NMR based binding assays to identify key hydroxy groups for intermolecular recognition. J. Am. Chem. Soc. 122, 6093-6099.
22. Mayer, M., and Meyer, B. (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123, 6108-6117.
23. Meyer, B., and Peters, T. (2003) NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew. Chem., Int. Ed. 42, 864-890.
24. Sandström, C., Berteau, O., Gemma, E., Oscarson, S., Kenne, L., and Gronenborn, A. M. (2004) Atomic mapping of the interactions between the antiviral agent Cyanovirin-N and oligomannosides by saturation-transfer difference NMR. Biochemistry 43, 13926-13931.
25. Barrientos, L. G., Matei, E., Lasala, F., Delgado, R., and Gronenborn, A. M. (2006) Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: Functional implications for viral entry inhibition. Protein Eng., Des. Sel. 19, 525-535.
26. Wang, Y. S., Liu, D. J., and Wyss, D. F. (2004) Competition STD NMR for the detection of high-affinity ligands and NMR-based screening. Magn. Reson. Chem. 42, 485-489.
27. Oscarson, S., and Tedebark, U. (1995) Synthesis of deoxy analogues of methyl 3,6-di-O-α-D-mannopyranosyl-α-D- mannopyranoside for studies of the binding site of Concanavalin A. Carbohydr. Res. 278, 271-287.
28. Gemma, E., Lahmann, M., and Oscarson, S. (2006) Synthesis of monodeoxy analogues of the trisaccharide α-D-Glcp-(1-3)-α-D- Manp-(1-2)-α-D-ManpOMe recognized by calreticuli/calnexin. Carbohydr. Res. 341, 1533-1542.
29. Boger, D. L., and Honda, T. (1994) Total synthesis of Bleomycin A2 and related agents. 4. Synthesis of the disaccharide subunit 2-O-(3O-carbamoyl-α-D-mannopyrannosyl)-L-gulopyranose and completion of the total synthesis of bleomycin A2. J. Am. Chem. Soc. 116, 5647-5656.
30. Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661-665.
31. Yan, J. L., Kline, A. D., Mo, H. P., Shapiro, M. J., and Zartler, E. R. (2003) The effect of relaxation on the epitope mapping by saturation transfer difference NMR. J. Magn. Reson. 163, 270-276.
32. Johnson, M. A., and Pinto, B. M. (2002) Saturation transfer difference 1D-TOCSY experiments to map the topography of oligosaccharides recognized by a monoclonal antibody directed against the cell-wall polysaccharide of group A Streptococcus. J. Am. Chem. Soc. 124, 15368-15374.
33. Meyer, M., and James, T. L. (2004) NMR-based characterization of phenothiazines as a RNA binding scaffold. J. Am. Chem. Soc. 126, 4453-4460.
34. 2O. J. Am. Chem. Soc. 124, 13376-13377.
35. Bhunia, A., Jayalakshmi, V., Benie, A. J., Schuster, O., Kelm, S., Krishna, N. R., and Peters, T. (2004) Saturation transfer difference NMR and computational modeling of a sialoadhesin-sialyl lactose complex. Carbohydr. Res. 339, 259-267.
36. Vold, R. L., Waugh, J. S., Klein, M. P., and Phelps, D. E. (1968) Measurement of spin relaxation in complex systems. J. Chem. Phys. 48, 3831.